[VRDN] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 20.21%
YoY- -217.24%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 2,182 4,784 1,192 1,631 718 462 756 103.11%
PBT -8,714 -4,661 -6,386 -5,834 -7,312 -6,980 -5,570 34.87%
Tax 361 167 77 113 102 30 -71 -
NP -8,714 -4,661 -6,386 -5,834 -7,312 -6,980 -5,570 34.87%
Tax Rate - - - - - - - -
Total Cost 10,896 9,445 7,578 7,465 8,030 7,442 6,326 43.83%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -399.36 -97.43 -535.74 -357.69 -1,018.38 -1,510.82 -736.77 -33.59%
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -4.31 -2.64 -4.30 -4.06 -5.12 -9.06 -7.23 -29.23%
EPS Diluted -4.31 -2.64 -4.30 -4.06 -5.12 -9.06 -7.23 -29.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.